-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
PROTAC-Hemagglutinin-Degrader-1
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/protac-hemagglutinin-degrader-1.gif)
| Category | Influenza Virus |
| Description | PROTAC Hemagglutinin Degrader-1 (Compound V3) is a potent PROTAC influenza hemagglutinin (HA) degrader with a median degradation concentration of 1.44 μM. PROTAC Hemagglutinin Degrader-1 shows broad-spectrum anti-influenza virus activity. |
Product Information
| Molecular Weight | 1072.48 |
| Molecular Formula | C61H93N5O9S |
| Purity | ≥98% (HPLC) |
| Solubility | In Vitro: DMSO : ≥ 50 mg/mL (57.35 mM) |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| In Vitro | PROTAC BET Degrader-1 (Compound 9) is a potent BET degrader based on PROTAC, decreases the level of BRD2, BRD3, and BRD4 proteins in RS4;11 cells at 3-10 nM, and inhibits the growth of this cell line with an IC50 of 4.3 nM, and 45.5 nM for MOLM-13 cells. |
| Target | PROTACs; Influenza Virus |
